Successful management of chronic myeloid leukemia with a complication of anti-SRP antibody-associated myopathy

被引：0
|
作者：
Morita, Kiyomi [1 ]
Nakamura, Fumihiko [1 ]
Sakuishi, Kaori [2 ]
Yamamoto, Tomotaka [2 ]
Shimizu, Jun [2 ]
Tsuji, Shoji [2 ]
Kurokawa, Mineo [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 05期
关键词：
SIGNAL RECOGNITION PARTICLE; IMATINIB; DERMATOMYOSITIS; RHABDOMYOLYSIS; DASATINIB; RISK;
D O I：
10.1080/10428194.2016.1233537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1242 / 1245
页数：4
相关论文
共 50 条
  • [41] Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies
    Wang, Zeng
    Jiang, Liyu
    Yan, Hao
    Xu, Zhifei
    Luo, Peihua
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (04) : 445 - 456
  • [42] Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
    M Ilander
    U Olsson-Strömberg
    H Schlums
    J Guilhot
    O Brück
    H Lähteenmäki
    T Kasanen
    P Koskenvesa
    S Söderlund
    M Höglund
    B Markevärn
    A Själander
    K Lotfi
    A Dreimane
    A Lübking
    E Holm
    M Björeman
    S Lehmann
    L Stenke
    L Ohm
    T Gedde-Dahl
    W Majeed
    H Ehrencrona
    S Koskela
    S Saussele
    F-X Mahon
    K Porkka
    H Hjorth-Hansen
    Y T Bryceson
    J Richter
    S Mustjoki
    Leukemia, 2017, 31 : 1108 - 1116
  • [43] Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
    Ilander, M.
    Olsson-Stromberg, U.
    Schlums, H.
    Guilhot, J.
    Bruck, O.
    Lahteenmaki, H.
    Kasanen, T.
    Koskenvesa, P.
    Soderlund, S.
    Hoglund, M.
    Markevarn, B.
    Sjalander, A.
    Lotfi, K.
    Dreimane, A.
    Lubking, A.
    Holm, E.
    Bjoreman, M.
    Lehmann, S.
    Stenke, L.
    Ohm, L.
    Gedde-Dahl, T.
    Majeed, W.
    Ehrencrona, H.
    Koskela, S.
    Saussele, S.
    Mahon, F-X
    Porkka, K.
    Hjorth-Hansen, H.
    Bryceson, Y. T.
    Richter, J.
    Mustjoki, S.
    LEUKEMIA, 2017, 31 (05) : 1108 - 1116
  • [44] Anti-Tr/DNER Antibody-Associated Ataxia in a Pediatric Hodgkin Lymphoma Survivor: Successful Treatment With Plasmapheresis and IVIG
    Adibi, Armin
    Adibi, Iman
    Danaei, Hamidreza
    PEDIATRIC BLOOD & CANCER, 2025, 72 (04)
  • [45] Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
    Gono, Takahisa
    Kawaguchi, Yasushi
    Ozeki, Eri
    Ota, Yuko
    Satoh, Takashi
    Kuwana, Masataka
    Hara, Masako
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 223 - 227
  • [46] Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies
    Shida, Ryutaro
    Iwakura, Takamasa
    Ohashi, Naro
    Ema, Chiemi
    Aoki, Taro
    Tashiro, Takeshi
    Ishigaki, Sayaka
    Isobe, Shinsuke
    Fujikura, Tomoyuki
    Kato, Akihiko
    Nakamura, Tomohiko
    Fujigaki, Yoshihide
    Shimizu, Akira
    Yasuda, Hideo
    INTERNAL MEDICINE, 2024, 63 (05) : 699 - 705
  • [47] Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery
    Yadav, Usha
    Solanki, Sohan Lal
    Yadav, Rupesh
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (03) : 484 - 486
  • [48] Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Sano, Haruhiko
    Okamoto, Sho
    Itamura, Hidekazu
    Yoshimura, Mariko
    Katsuya, Hiroo
    Ando, Toshihiko
    Kimura, Shinya
    HEMATOLOGY, 2022, 27 (01) : 1171 - 1175
  • [49] Anti-neutrophil cytoplasmic antibody-associated pauci-immune glomerulonephritis in a patient with chronic lymphocytic leukaemia
    Yeung, C. S.
    Cheung, C. Y.
    Chan, P. T.
    Li, John W.
    Chak, W. L.
    Chau, K. F.
    HONG KONG MEDICAL JOURNAL, 2016, 22 (02) : 178 - 180
  • [50] Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    E Jabbour
    M Deininger
    A Hochhaus
    Leukemia, 2011, 25 : 201 - 210
12345